Pre-emptive Scalp Infiltration with Triamcinolone Acetonide Plus Ropivacaine for Post-Craniotomy Pain in Children

Last updated: January 12, 2025
Sponsor: Beijing Tiantan Hospital
Overall Status: Active - Recruiting

Phase

4

Condition

Pain

Treatment

The triamcinolone acetonide plus ropivacaine group

The ropivacaine group

Clinical Study ID

NCT06779396
KY 2018-066-02-4
  • Ages 2-12
  • All Genders

Study Summary

At present, pediatric postoperative analgesia has not been fully understood and controlled, particularly craniotomy surgery. On the one hand, professional evaluation of postoperative pain for young children is difficult; on the other hand, the particularity of craniotomy adds (such as consciousness obstacle, sleepiness, et al) disturbance to the pain assessment in children. Although opioids administration is regarded as the first-line analgesic for post-craniotomy pain management, it may be associated with delayed awakening, respiratory depression, hypercarbia and it may interfere with the neurologic examination. For the avoidance of side-effects of systemic opioids, local anesthetics administered around the incision have been performed clinically. However, some studies revealed that the analgesic effect of local anesthetics was unsatisfactory due to its short pain relief duration, steroid as adjuvant can enhance postoperative analgesia and prolong postoperative analgesia time. As is reported that postoperative pain of craniotomy is mainly caused by skin incision and reflection of muscles, preventing the liberation of inflammatory mediators around the incision seems to be more effective than simply blocking nerve conduction.However, there has not been reported about local application of triamcinolone acetonide on scalp infiltration. Thus, the investigators suppose that pre-emptive scalp infiltration with steroid (triamcinolone acetonide) plus local anesthetic (ropivacaine) could relieve postoperative pain after craniotomy in children.

Eligibility Criteria

Inclusion

Inclusion Criteria:

-(1) Age 2 to 12 years. (2) American Society of Anesthesiologists (ASA) physical status I or II. (3)Participates with an anticipated fully recovery within 2 hours postoperatively.

(4)Informed consent by parent(s) and/or legal guardian.

Exclusion

Exclusion Criteria:

  • (1) Allergy to local anesthetics. (2) Pediatric patients aged>12 or <2 years. (3)Under medication with analgesic drugs. (4) Psychiatric disorders. (5) Uncontrolledepilepsy. (6) Chronic headache. (7) Peri-incisional infection. (8) Coagulopathy orbleeding disorder. (9) Patients who are expected to remain intubated and mechanicalventilation after surgery.

(10) Emergency craniotomies. (11) Patients with cardiac insufficiency or severe kidney or liver diseases. (12) Patients whose authorized surrogates are unwilling to participate in the study

Study Design

Total Participants: 128
Treatment Group(s): 2
Primary Treatment: The triamcinolone acetonide plus ropivacaine group
Phase: 4
Study Start date:
January 10, 2025
Estimated Completion Date:
May 31, 2025

Connect with a study center

  • Beijing Tiantan Hospital

    Beijing, Beijing 100070
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.